Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Eric Karas
12 Jun 2026
Chief Commercial Officer
Sold after exercise
25,000
$10.00
$250.00K
Brian Dorsey
13 Nov 2025
Chief Operating Officer
Sold after exercise
21,828
$8.71
$190.05K
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
136,380
$8.86
$1.21M
Justin Chakma
12 Nov 2025
Chief Business Officer
Sold after exercise
30,000
$8.91
$267.36K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 4
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 426,828
History held since 7 Dec 2020